20.760 articles found

The Dopamine Dancer: The Value of Holistic Autotherapy in Parkinson's Disease.

Hellevik A, Wirdefeldt K, Lees AJ.

Mov Disord Clin Pract · 2024-08-02

DOI: 10.1002/mdc3.14166PMID: 39091197

Antibody conjugated targeted nanotherapy epigenetically inhibits calpain-mediated mitochondrial dysfunction to attenuate Parkinson’s disease

Biswal L, Sahu VK, Sardoiwala MN, Karmakar S, Choudhury SR.

Carbohydrate Polymers. · 2024-08-01

Therapeutic Importance of Exercise in Neuroplasticity in Adults with Neurological Pathology: Systematic Review.

Cardoso SV, Fernandes SR, Tomás MT.

Int J Exerc Sci · 2024-08-01

DOI: 10.70252/vzwf7949PMID: 39257645

The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson's therapeutics.

Rubilar JC, Outeiro TF, Klein AD.

Brain · 2024-08-01

DOI: 10.1093/brain/awae070PMID: 38437875

ASCL1-mediated direct reprogramming: converting ventral midbrain astrocytes into dopaminergic neurons for Parkinson's disease therapy.

Yong SH, Kim SM, Kong GW, Ko SH, Lee EH, Oh Y, Park CH.

BMB Rep · 2024-08-01

PMID: 38649147

Correction: Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease.

Nasser A, Gomeni R, Ceresoli-Borroni G, Xie L, Busse GD, Melyan Z, Rubin J.

J Pharmacokinet Pharmacodyn · 2024-08-01

DOI: 10.1007/s10928-024-09923-wPMID: 38816542

[Influence of periodontal microbial homeostasis on neurodegenerative diseases and its therapeutic perspectives].

Kong LWY, He XT, Chen FM, Li X.

Zhonghua Kou Qiang Yi Xue Za Zhi · 2024-08-01

DOI: 10.3760/cma.j.cn112144-20231027-00225PMID: 39036920

Post hoc analysis of the characteristics and treatment needs of patients with dementia with Lewy bodies (DLB) and their caregivers and their physicians' awareness of those treatment needs according to the duration after diagnosis of DLB.

Ikeda M, Toya S, Manabe Y, Yamakage H, Hashimoto M.

Int J Geriatr Psychiatry · 2024-08-01

DOI: 10.1002/gps.6122PMID: 39085743

Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi Is a Promising Candidate for the Treatment of Cancer, Alzheimer's Disease, and Obesity.

Bartkowiak-Wieczorek J, Malesza M, Malesza I, Hadada T, Winkler-Galicki J, Grzelak T, Mądry E.

Nutrients · 2024-08-01

DOI: 10.3390/nu16152509PMID: 39125389

Editor's Note on: Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From the American Physical Therapy Association, Volume 102, Issue 4, April 2022, pzab302, https://doi.org/10.1093/ptj/pzab302.

Check source for author details

Phys Ther · 2024-08-01

DOI: 10.1093/ptj/pzae031PMID: 39164876

Beta₂-Adrenergic Suppression of Neuroinflammation in Treatment of Parkinsonism, with Relevance for Neurodegenerative and Neoplastic Disorders.

Inchiosa MA.

Biomedicines · 2024-08-01

DOI: 10.3390/biomedicines12081720PMID: 39200184

The Use of Neurotrophic Factors as a Promising Strategy for the Treatment of Neurodegenerative Diseases (Review).

Fursa GA, Andretsova SS, Shishkina VS, Voronova AD, Karsuntseva EK, Chadin AV, Reshetov IV, Stepanova OV, Chekhonin VP.

Bull Exp Biol Med · 2024-08-01

DOI: 10.1007/s10517-024-06218-5PMID: 39266924